A5060506670- Cardiac pacing and defibrillation studies
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac Valve Diseases and Treatments
- Heart Rate Variability and Autonomic Control
- Cardiac Arrest and Resuscitation
- Cardiomyopathy and Myosin Studies
- Cardiac Imaging and Diagnostics
- Cardiac Structural Anomalies and Repair
- Heart Failure Treatment and Management
- Cardiovascular Effects of Exercise
- Transplantation: Methods and Outcomes
- Cardiovascular Syncope and Autonomic Disorders
- Mechanical Circulatory Support Devices
- Acute Kidney Injury Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Obstructive Sleep Apnea Research
- Cardiovascular Health and Risk Factors
- Infective Endocarditis Diagnosis and Management
- ECG Monitoring and Analysis
- Cardiovascular Disease and Adiposity
- Acute Myocardial Infarction Research
Minneapolis VA Health Care System
2016-2025
University of Minnesota
2015-2024
Veterans Health Administration
2012-2024
University of Minnesota Medical Center
2011-2024
Minneapolis VA Medical Center
2015-2024
Minneapolis Heart Institute Foundation
2005-2023
Government of the United States of America
2021
University of Pennsylvania
2016-2017
Asan Medical Center
2017
University of Virginia
2017
Sudden cardiac death after myocardial infarction (MI) has not been assessed recently in the community. Risk stratification for sudden MI commonly relies on baseline characteristics and little is known about relationship between recurrent ischemia or heart failure death.To evaluate risk of impact death.Population-based surveillance study 2997 residents (mean [SD] age, 67 [14] years; 59% were men) experiencing an Olmsted County, Minnesota, 1979 2005, followed up through February 29,...
It is unknown whether atrial fibrillation (AF) associated with an increased risk of sudden cardiac death (SCD) in the general population. This association was examined 2 population-based cohorts.In Atherosclerosis Risk Communities (ARIC) Study, we analyzed data from 15 439 participants (baseline age, 45-64 years; 55.2% women; and 26.6% black) baseline (1987-1989) through December 31, 2001. In Cardiovascular Health Study (CHS), 5479 ≥65 58.2% 15.4% (first cohort, 1989-1990; second 1992-1993)...
<h3>Objective</h3> To examine the association of body mass index (BMI), waist circumference (WC) and hip ratio (WHR) with sudden cardiac death (SCD) in community dwelling individuals. <h3>Methods</h3> Data from a multicentre, prospective, cohort study 14 941 men women (African American, white), aged 45–64 years, participating Atherosclerosis Risk Communities was analysed. Obesity measures were assessed at baseline (1987–1989). SCD adjudicated by committee. <h3>Results</h3> At enrolment...
Most sudden cardiac death (SCD) events occur in the general population among persons who do not have any prior history of clinical heart disease. We sought to develop a predictive model SCD US adults.
Background— Nonvalvular atrial fibrillation is a major cause of thromboembolic events. In comparison with fibrillation–related stroke, extracranial systemic embolic events (SEEs) remain poorly defined. Methods and Results— All suspected SEEs reported among 37 973 participants 4 large contemporary randomized clinical trials anticoagulation in were independently readjudicated for objective evidence sudden loss perfusion limb or organ. Over 91 746 patient-years follow-up, 221 occurred 219...
Background In 2013 the Minnesota Resuscitation Consortium developed an organized approach for management of patients resuscitated from shockable rhythms to gain early access cardiac catheterization laboratory (CCL) in metro area Minneapolis‐St. Paul. Methods and Results Eleven hospitals with 24/7 percutaneous coronary intervention capabilities agreed provide (within 6 hours arrival at Emergency Department) CCL intention perform revascularization outpatients who were successfully ventricular...
Background: Implantable cardioverter-defibrillators are used to prevent sudden cardiac death in patients with sarcoidosis. The most recent recommendations for implantable cardioverter-defibrillator implantation these the 2017 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline Management Patients With Ventricular Arrhythmias and Prevention Sudden Cardiac Death. These recommendations, based on observational studies or expert opinion, have not been...
<h3>Importance</h3> Improvement in left ventricular ejection fraction (EF) to >35% occurs many patients with reduced EF at baseline. To our knowledge, whether implantable cardioverter defibrillator (ICD) therapy improves survival for these is unknown. <h3>Objective</h3> examine the efficacy of ICD reducing risk all-cause mortality and sudden cardiac death among an ≤35% baseline, or without improvement during follow-up. <h3>Design, Setting, Participants</h3> This retrospective analysis...
Approximately 20,000 permanent pacemakers (PPMs) are implanted annually for bradycardia or atrioventricular (AV) block after cardiac surgery. Little is known about the long-term pacing and mortality outcomes temporal trends of these patients.We examined 6,268 consecutive patients who underwent surgery at Minneapolis Veterans Administration Medical Center between 1987 2010. Patients had a PPM within 30 days were identified. Pacemaker interrogation records retrospectively reviewed was...